BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 25770020)

  • 1. Demand-side strategies to deal with moral hazard in public insurance for long-term care.
    Bakx P; Chernichovsky D; Paolucci F; Schokkaert E; Trottmann M; Wasem J; Schut F
    J Health Serv Res Policy; 2015 Jul; 20(3):170-6. PubMed ID: 25770020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managed competition in the Netherlands-a qualitative study.
    Heinemann S; Leiber S; Gress S
    Health Policy; 2013 Feb; 109(2):113-21. PubMed ID: 23031431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk adjustment and risk selection on the sickness fund insurance market in five European countries.
    van de Ven WP; Beck K; Buchner F; Chernichovsky D; Gardiol L; Holly A; Lamers LM; Schokkaert E; Shmueli A; Spycher S; Van de Voorde C; van Vliet RC; Wasem J; Zmora I
    Health Policy; 2003 Jul; 65(1):75-98. PubMed ID: 12818747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk adjustment and risk selection in Europe: 6 years later.
    van de Ven WP; Beck K; Van de Voorde C; Wasem J; Zmora I
    Health Policy; 2007 Oct; 83(2-3):162-79. PubMed ID: 17270311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk selection in a regulated health insurance market: a review of the concept, possibilities and effects.
    van Kleef RC; van de Ven WP; van Vliet RC
    Expert Rev Pharmacoecon Outcomes Res; 2013 Dec; 13(6):743-52. PubMed ID: 24219050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Capping risk adjustment?
    Eugster P; Sennhauser M; Zweifel P
    J Health Econ; 2010 Jul; 29(4):499-507. PubMed ID: 20462647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards a reinforced agency role of health insurers in Belgium and The Netherlands.
    Schut FT; van Doorslaer EK
    Health Policy; 1999 Jul; 48(1):47-67. PubMed ID: 10539585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Has solidarity survived? A comparative analysis of the effect of social health insurance reform in four European countries.
    Maarse H; Paulus A
    J Health Polit Policy Law; 2003 Aug; 28(4):585-614. PubMed ID: 12956517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk adjustment in Switzerland.
    Beck K; Spycher S; Holly A; Gardiol L
    Health Policy; 2003 Jul; 65(1):63-74. PubMed ID: 12818746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statutory health insurance competition in Europe: a four-country comparison.
    Thomson S; Busse R; Crivelli L; van de Ven W; Van de Voorde C
    Health Policy; 2013 Mar; 109(3):209-25. PubMed ID: 23395277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Netherlands: health system review.
    Schäfer W; Kroneman M; Boerma W; van den Berg M; Westert G; Devillé W; van Ginneken E
    Health Syst Transit; 2010; 12(1):v-xxvii, 1-228. PubMed ID: 21132996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Managed care in four managed competition OECD health systems.
    Shmueli A; Stam P; Wasem J; Trottmann M
    Health Policy; 2015 Jul; 119(7):860-73. PubMed ID: 25776034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supervision in social health insurance: a four country study.
    Maarse H; Paulus A; Kuiper G
    Health Policy; 2005 Mar; 71(3):333-46. PubMed ID: 15694500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Swiss and Dutch "consumer-driven health care": ideal model or reality?
    Okma KG; Crivelli L
    Health Policy; 2013 Feb; 109(2):105-12. PubMed ID: 23122805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Notes on the planned German health fund model].
    Robra BP; Mayrhofer T
    Gesundheitswesen; 2006 Oct; 68(10):650-2. PubMed ID: 17099827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Managed competition in the Netherlands: Do insurers have incentives to steer on quality?
    Stolper KCF; Boonen LHHM; Schut FT; Varkevisser M
    Health Policy; 2019 Mar; 123(3):293-299. PubMed ID: 30268584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consumer mobility in social health insurance markets : a five-country comparison.
    Laske-Aldershof T; Schut E; Beck K; Gress S; Shmueli A; Van de Voorde C
    Appl Health Econ Health Policy; 2004; 3(4):229-41. PubMed ID: 15901197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Managed competition with prefunding: the solution for long-term care?
    Lucas D
    Milbank Q; 1996; 74(4):571-97. PubMed ID: 8941262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Belgium: risk adjustment and financial responsibility in a centralised system.
    Schokkaert E; Van de Voorde C
    Health Policy; 2003 Jul; 65(1):5-19. PubMed ID: 12818742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk sharing as a supplement to imperfect capitation: a tradeoff between selection and efficiency.
    van Barneveld EM; Lamers LM; van Vliet RC; van de Ven WP
    J Health Econ; 2001 Mar; 20(2):147-68. PubMed ID: 11252368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.